Stephen K. Williamson

机构：University of Kansas Medical Center · ORCID：0000-0003-4118-1242

发表论文 228 篇 · 总被引 8107 次 · h-index 38

代表论文

• A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer (2023 · Journal of Clinical Oncology · 被引 119)
• Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer (2022 · JAMA Oncology · 被引 99)
• Clinical and biomarker results from a phase II trial of combined cabozantinib and durvalumab in patients with chemotherapy-refractory colorectal cancer (CRC): CAMILLA CRC cohort (2024 · Nature Communications · 被引 49)
• Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial results (2023 · Cell Reports Medicine · 被引 38)
• Phase II trial of cabozantinib (Cabo) plus durvalumab (Durva) in chemotherapy refractory patients with advanced mismatch repair proficient/microsatellite stable (pMMR/MSS) colorectal cancer (CRC): CAMILLA CRC cohort results. (2022 · Journal of Clinical Oncology · 被引 26)
• Evaluation of the Durability of the Immune Humoral Response to COVID-19 Vaccines in Patients With Cancer Undergoing Treatment or Who Received a Stem Cell Transplant (2022 · JAMA Oncology · 被引 23)